Does initial dosing of levothyroxine in infants with congenital hypothyroidism lead to frequent dose adjustments secondary to iatrogenic hyperthyroidism on follow-up?
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Background: Congenital hypothyroidism (CH) is the most common preventable cause of intellectual disability. The recommended starting dose of levothyroxine (LT4) is between 10 and 15 μg/kg, an extremely wide range. We hypothesized that a sizable proportion of newborns treated for CH at the higher end of the dosage range become biochemically hyperthyroid at a follow-up visit. Methods: This study is a retrospective chart review of infants with CH between 2002 and 2012. Results: Of the 104 patients included in this analysis, the average age at diagnosis was 11 days and the average starting dose of LT4 was 12±2.5 μg/kg. At follow-up, 36.5% required a dose reduction because of iatrogenic hyperthyroxinemia, 51% required no dose adjustment and 12.5% required a dose increase due to an elevated thyroid stimulating hormone (TSH). The starting doses of LT4 for those requiring a dose reduction, those not requiring an adjustment and those requiring an increase in the dose were 13.2±2.4, 11.5±2.1 and 10.3±2.6 μg/kg/day, respectively (p≤0.0001). Of the 34% of infants treated with an initial dose of >12.5 μg/day, 57.1% required a dose reduction at follow-up, compared to 26.1% of those whose initial starting dose was ≤12.5 μg/kg/day (p=0.007). Conclusions: Following the guidelines for initiating therapy for CH, 36.5% of the infants required a dose reduction for iatrogenic hyperthyroxinemia. These infants received a higher dose of LT4 than the infants who either required no adjustment or required an increase in the dose. A narrower range for initial dosing in CH may be appropriate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the highest doses within the recommended range of 10–15 μg/kg per day resulted in more dose adjustments because of hyperthyroxinemia (105–107);”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Update of Newborn Screening and Therapy for Congenital Hypothyroidism
American Academy of Pediatrics, Rose, S. R., and the Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown, R. S., and the Public Health Committee, & Lawson Wilkins Pediatric Endocrine Society (2006) · Pediatrics · doi:10.1542/peds.2006-0915 · Cited by 798
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569
Rastogi, M. V., & LaFranchi, S. H. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-17 · Cited by 552
Increase in congenital hypothyroidism in New York State and in the United States
Harris, K. B., & Pass, K. A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.03.012 · Cited by 270
Grosse, S. D., & Van Vliet, G. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2010.190280 · Cited by 222
Selva, K. A., Harper, A., Downs, A., Blasco, P. A., & LaFranchi, S. H. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.07.024 · Cited by 190
Dimitropoulos, A., Molinari, L., Etter, K., Torresani, T., Lang-Muritano, M., Jenni, O. G., Largo, R. H., & Latal, B. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31818d2030 · Cited by 114
Initial treatment dose of L-thyroxine in congenital hypothyroidism
Selva, K. A., Mandel, S. H., Rien, L., Sesser, D., Miyahira, R., Skeels, M., Nelson, J. C., & LaFranchi, S. H. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.128887 · Cited by 99
Bongers-Schokking, J. J., Resing, W. C. M., de Rijke, Y. B., de Ridder, M. A. J., & de Muinck Keizer-Schrama, S. M. P. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2175 · Cited by 94
Bakker, B., Kempers, M. J. E., De Vijlder, J. J. M., Van Tijn, D. A., Wiedijk, B. M., Van Bruggen, M., & Vulsma, T. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01632.x · Cited by 48
A novel therapeutic paradigm to treat congenital hypothyroidism
Mathai, S., Cutfield, W. S., Gunn, A. J., Webster, D., Jefferies, C., Robinson, E., & Hofman, P. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03172.x · Cited by 44
Tuhan, H., Abaci, A., Cicek, G., Anik, A., Catli, G., Demir, K., & Bober, E. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0047 · Cited by 21
Vaidyanathan, P., Pathak, M., & Kaplowitz, P. B. (2012) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2012-0025 · Cited by 18
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision)
Nagasaki, K., Minamitani, K., Nakamura, A., Kobayashi, H., Numakura, C., Itoh, M., Mushimoto, Y., Fujikura, K., Fukushi, M., & Tajima, T. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0063 · Cited by 48
Esposito, A., Vigone, M. C., Polizzi, M., Wasniewska, M. G., Cassio, A., Mussa, A., Gastaldi, R., Mase, R. D., Vincenzi, G., Pozzi, C., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.923448 · Cited by 39
Pediatric Quality of Life in Congenital Hypothyroidism: an Indonesian Study
Rochmah, N., Faizi, M., Dewanti, C. N., & Suryawan, A. (2020) · International Journal of Thyroidology · doi:10.11106/ijt.2020.13.2.150 · Cited by 13
He, S., Ma, X., Yang, J., & Li, L. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01061-z · Cited by 11
“Craven and Frank (2018) reported that a high initial levothyroxine dosage (> 12.5 μg/kg·d) may have caused hyperthyroidism.”
BackgroundInfluential
Metadata
- Authors
- Craven, M., & Frank, G. R.
- Affiliations
- Northwell Health (US)
- Corresponding author
- Frank, Graeme R.
- ORCID
- Craven, Meghan
- Venue
- Journal of Pediatric Endocrinology and Metabolism
- Publisher
- Walter de Gruyter GmbH
- Published
- 2018-05-01
- Volume
- 31
- Issue
- 6
- Pages
- 597-600
- ISSN
- 0334-018X (ISSN-L)
- 2191-0251
- OpenAlex
- W2800484336
- Cited by
- 14
- References
- 13
- Citations by year
- 2026: 2 · 2025: 1 · 2022: 5 · 2021: 2 · 2020: 3 · 2018: 1
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Pediatric Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- congenital hypothyroidism, levothyroxine, initial dose, iatrogenic hyperthyroidism, dose adjustment, infants, thyroid-stimulating hormone, hyperthyroxinemia
- MeSH terms
- Congenital Hypothyroidism, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, Hyperthyroidism, Iatrogenic Disease, Infant, Infant, Newborn, Male, Retrospective Studies, Thyroid Hormones, Thyroxine, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.